Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys
Norman L. Letvin(Beth Israel Deaconess Medical Center), Gary J. Nabel(National Institutes of Health), Linh Mach(Beth Israel Deaconess Medical Center), James B. Whitney(Beth Israel Deaconess Medical Center), George M. Shaw(International AIDS Vaccine Initiative), Stephen D. Schmidt(Philips (United States)), Harikrishnan Balachandran(The University of Sydney), So‐Yon Lim(Beth Israel Deaconess Medical Center), Alan Dodson(Bioqual), Miguel Lacerda(University of Cape Town), Wendy W. Yeh(VIR Biotechnology (United States)), Philip J. Norris(University of California, San Francisco), Mohammed Asmal(Beth Israel Deaconess Medical Center), Adam P. Buzby(University of Vienna), John-Paul Todd(National Institutes of Health), Sheila M. Keating(University of California, San Francisco), Rebecca Gelman(Dana-Farber Cancer Institute), John R. Mascola(National Institute of Allergy and Infectious Diseases), Michael G. Hudgens(University of North Carolina at Chapel Hill), Michael S. Seaman(Beth Israel Deaconess Medical Center), Yue Sun(Nanyang Technological University), Peter B. Gilbert(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jinrong Zhang(Hubei University of Chinese Medicine), Ling Shen(Hunan University), David C. Montefiori(Duke University), Srinivas S. Rao(University of Vienna), Cathal Seoighe(Ollscoil na Gaillimhe – University of Galway)
Cited by 183
Related Papers
Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
|Cell|2020|4.5k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k